Loading...

RGNT

RGNT

REGENTIS BIOMATERIALS LTD

(RGNT)

2025 6-K

Surgeon Training Launch

8 Jun '26

AGM Notice Update

4 Jun '26

6-K Filing

28 May '26

Financial Results Update

24 Feb '26

European Expansion

17 Feb '26

Management Change

5 Feb '26

Clinical Expansion Announce...

29 Jan '26

Knee Repair Breakthrough

20 Jan '26

Cartilage Repair Innovation

6 Jan '26

Management Change

6 Jan '26

Patent Granted

18 Dec '25

IPO Closure Report

5 Dec '25

External Links:

SEC

Regentis Biomaterials Ltd. announced on December 18, 2025, that it received a new U.S. patent for its regenerative cartilage repair product, GelrinC. This filing outlines the company's advancements in biomedicine and is considered significant.

AI Assistant

REGENTIS BIOMATERIALS LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.